Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.03 (-11.87%)
Close on Nov 13, 2026Market cap $3.86MP/E –Yield –
Traws Pharma cash
Cash and short-term investments held at the end of each period.
Traws Pharma's cash was $5.02M at Jun 30, 2026. For fiscal 2025 it was $3.82M, down 82.1% from the year before. Over ten years it grew -15.2% a year on average. The highest annual figure on record is $81.53M in fiscal 2012.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.82M | -82.1% |
| FY2024 | Dec 31, 2024 | $21.34M | +2.5% |
| FY2023 | Dec 31, 2023 | $20.82M | -46.3% |
| FY2022 | Dec 31, 2022 | $38.76M | -29.6% |
| FY2021 | Dec 31, 2021 | $55.07M | +189.5% |
| FY2020 | Dec 31, 2020 | $19.03M | -16.3% |
| FY2019 | Dec 31, 2019 | $22.73M | +33.9% |
| FY2018 | Dec 31, 2018 | $16.97M | +321.7% |
| FY2017 | Dec 31, 2017 | $4.02M | -81.2% |
| FY2016 | Dec 31, 2016 | $21.45M | +8.1% |
| FY2015 | Dec 31, 2015 | $19.85M | -54.5% |
| FY2014 | Dec 31, 2014 | $43.58M | -27.4% |
| FY2013 | Dec 31, 2013 | $60.01M | -26.4% |
| FY2012 | Dec 31, 2012 | $81.53M | +2905.0% |
| FY2011 | Dec 31, 2011 | $2.71M | -63.0% |
| FY2010 | Dec 31, 2010 | $7.34M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.02M | -61.7% |
| Q1 FY2026 | Mar 31, 2026 | $3.13M | -80.3% |
| Q4 FY2025 | Dec 31, 2025 | $3.82M | -82.1% |
| Q3 FY2025 | Sep 30, 2025 | $6.42M | +18.7% |
| Q2 FY2025 | Jun 30, 2025 | $13.08M | -22.5% |
| Q1 FY2025 | Mar 31, 2025 | $15.94M | -2.8% |
| Q4 FY2024 | Dec 31, 2024 | $21.34M | +2.5% |
| Q3 FY2024 | Sep 30, 2024 | $5.41M | -78.6% |
| Q2 FY2024 | Jun 30, 2024 | $16.89M | -43.2% |
| Q1 FY2024 | Mar 31, 2024 | $16.39M | -52.1% |
| Q4 FY2023 | Dec 31, 2023 | $20.82M | -46.3% |
| Q3 FY2023 | Sep 30, 2023 | $25.24M | -40.8% |
| Q2 FY2023 | Jun 30, 2023 | $29.73M | -36.1% |
| Q1 FY2023 | Mar 31, 2023 | $34.22M | -32.6% |
| Q4 FY2022 | Dec 31, 2022 | $38.76M | -29.6% |
| Q3 FY2022 | Sep 30, 2022 | $42.61M | -28.2% |
| Q2 FY2022 | Jun 30, 2022 | $46.53M | +6.5% |
| Q1 FY2022 | Mar 31, 2022 | $50.77M | +5.8% |
| Q4 FY2021 | Dec 31, 2021 | $55.07M | +189.5% |
| Q3 FY2021 | Sep 30, 2021 | $59.38M | +145.4% |
| Q2 FY2021 | Jun 30, 2021 | $43.71M | +60.5% |
| Q1 FY2021 | Mar 31, 2021 | $48.01M | +54.7% |
| Q4 FY2020 | Dec 31, 2020 | $19.03M | -16.3% |
| Q3 FY2020 | Sep 30, 2020 | $24.20M | +401.9% |
| Q2 FY2020 | Jun 30, 2020 | $27.23M | +362.9% |
| Q1 FY2020 | Mar 31, 2020 | $31.04M | +198.5% |
| Q4 FY2019 | Dec 31, 2019 | $22.73M | +33.9% |
| Q3 FY2019 | Sep 30, 2019 | $4.82M | -78.5% |
| Q2 FY2019 | Jun 30, 2019 | $5.88M | -80.1% |
| Q1 FY2019 | Mar 31, 2019 | $10.40M | +43.1% |
| Q4 FY2018 | Dec 31, 2018 | $16.97M | +321.7% |
| Q3 FY2018 | Sep 30, 2018 | $22.38M | +194.5% |
| Q2 FY2018 | Jun 30, 2018 | $29.54M | +97.1% |
| Q1 FY2018 | Mar 31, 2018 | $7.26M | -52.8% |
| Q4 FY2017 | Dec 31, 2017 | $4.02M | -81.2% |
| Q3 FY2017 | Sep 30, 2017 | $7.60M | -70.5% |
| Q2 FY2017 | Jun 30, 2017 | $14.99M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.39M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.45M | – |
| Q3 FY2016 | Sep 30, 2016 | $25.78M | – |
See a number that looks wrong?